C. Siewert
Max Planck Society
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by C. Siewert.
Biotechnology and Bioengineering | 2010
Michael W. Wolff; C. Siewert; Sara Post Hansen; Rene Faber; Udo Reichl
A purification scheme for cell culture‐derived smallpox vaccines based on an orthogonal downstream process of pseudo‐affinity membrane adsorbers (MA) and hydrophobic interaction chromatography (HIC) was investigated. The applied pseudo‐affinity chromatography, based on reinforced sulfated cellulose and heparin‐MA, was optimized in terms of dynamic binding capacities, virus yield and process productivity. HIC was introduced as a subsequent method to further reduce the DNA content. Therefore, two screens were undertaken. First, several HIC ligands were screened for different adsorption behavior between virus particles and DNA. Second, elution from pseudo‐affinity MA and adsorption of virus particles onto the hydrophobic interaction matrix was explored by a series of buffers using different ammonium sulfate concentrations. Eventually, variations between different cultivation batches and buffer conditions were investigated.The most promising combination, a sulfated cellulose membrane adsorber with subsequent phenyl HIC resulted in overall virus particle recoveries ranging from 76% to 55% depending on the product batch and applied conditions. On average, 61% of the recovered virus particles were infective within all tested purification schemes and conditions. Final DNA content varied from 0.01% to 2.5% of the starting material and the level of contaminating protein was below 0.1%. Biotechnol. Bioeng. 2010;107: 312–320.
Biotechnology and Bioengineering | 2009
Michael W. Wolff; C. Siewert; S. Lehmann; Sara Post Hansen; Rene Djurup; Rene Faber; Udo Reichl
Smallpox is an acute, highly infectious viral disease unique to humans, and responsible for an estimated 300–500 million deaths in the 20th century. Following successful vaccination campaigns through the 19th and 20th centuries, smallpox was declared eradicated by the World Health Organization in 1980. However, the threat of using smallpox as a biological weapon prompted efforts of some governments to produce smallpox vaccines for emergency preparedness. An additional aspect for the interest in smallpox virus is its potential use as a platform technology for vector vaccines. In particular, the latter requires a high safety level for routine applications. IMVAMUNE®, a third generation smallpox vaccine based on the attenuated Modified Vaccinia Ankara (MVA) virus, demonstrates superior safety compared to earlier generations and represents therefore an interesting choice as viral vector. Current downstream production processes of Vaccinia virus and MVA are mainly based on labor‐intensive centrifugation and filtration methods, requiring expensive nuclease treatment in order to achieve sufficient low host‐cell DNA levels for human vaccines. This study compares different ion exchange and pseudo‐affinity membrane adsorbers (MA) to capture chicken embryo fibroblast cell‐derived MVA‐BN® after cell homogenization and clarification. In parallel, the overall performance of classical bead‐based resin chromatography (Cellufine® sulfate and Toyopearl® AF‐Heparin) was investigated. The two tested pseudo‐affinity MA (i.e., sulfated cellulose and heparin) were superior over the applied ion exchange MA in terms of virus yield and contaminant depletion. Furthermore, studies confirmed an expected increase in productivity resulting from the increased volume throughput of MA compared to classical bead‐based column chromatography methods. Overall virus recovery was ∼60% for both pseudo‐affinity MA and the Cellufine® sulfate resin. Depletion of total protein ranged between 86% and 102% for all tested matrices. Remaining dsDNA in the product fraction varied between 24% and 7% for the pseudo‐affinity chromatography materials. Cellufine® sulfate and the reinforced sulfated cellulose MA achieved the lowest dsDNA product contamination. Finally, by a combination of pseudo‐affinity with anion exchange MA a further reduction of host‐cell DNA was achieved. Biotechnol. Bioeng. 2010. 105: 761–769.
AICHE Annual Meeting | 2008
Michael W. Wolff; C. Siewert; S. Lehmann; L. Opitz; S. P. Hansen; R. Djurup; R. Faber; Udo Reichl
5th Conference Analysis of Microbial Cells at Single Cell Level | 2011
Marc Rüger; C. Siewert; Sabine Kluge; Marcus Hoffmann; Dirk Benndorf; Erdmann Rapp; Udo Reichl
Vaccines R&D | 2010
Michael W. Wolff; L. Opitz; C. Siewert; S. Lehmann; S. P. Hansen; R. Faber; Udo Reichl
Vaccine Production & Manufacturing | 2010
Michael W. Wolff; L. Opitz; C. Siewert; S. Post Hansen; Rene Faber; Udo Reichl
Recovery of Biological Products XIV | 2010
Michael W. Wolff; L. Opitz; C. Siewert; S. Lehmann; Sara Post Hansen; Rene Faber; Udo Reichl
ISPPP 2010 | 2010
Michael W. Wolff; T. Kröber; C. Siewert; A. Neumann; S. Lehmann; S. Hansen; R. Faber; Udo Reichl
Vaccines Europe | 2009
Michael W. Wolff; L. Opitz; C. Siewert; N. Petermann; M. Meininger; S. Lehmann; S.P. Hansen; R. Faber; Udo Reichl
29th International Symposium & Exhibit on the Separation of Proteins, Peptides and Polynucleotides | 2009
Michael W. Wolff; L. Opitz; C. Siewert; N. Petermann; M. Meininger; S. Lehmann; S.P. Hansen; R. Faber; Udo Reichl